| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0188-4409(01)00268-5 |
| P698 | PubMed publication ID | 11395182 |
| P2093 | author name string | González-Burgos I | |
| Cervantes M | |||
| Letechipía-Vallejo G | |||
| P2860 | cites work | Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 r | Q63484490 |
| Melatonin reduces H2O2-induced lipid peroxidation in homogenates of different rat brain regions | Q71020680 | ||
| Brain cell death following ischemia and reperfusion | Q104176973 | ||
| Recommendations for standards regarding preclinical neuroprotective and restorative drug development | Q33785562 | ||
| Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin | Q33834167 | ||
| Significance of melatonin in antioxidative defense system: reactions and products | Q33909992 | ||
| Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo | Q33971469 | ||
| Melatonin stimulates brain glutathione peroxidase activity. | Q34719082 | ||
| Selective vulnerability of the hippocampus in brain ischemia | Q36501847 | ||
| Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. | Q36803177 | ||
| Oxygen radical mechanisms of brain injury following ischemia and reperfusion | Q36851027 | ||
| Mechanisms of ischemic cerebral injury | Q39149075 | ||
| Global brain ischemia and reperfusion | Q40986264 | ||
| Role of oxidants in ischemic brain damage | Q40998721 | ||
| Prophylactic actions of melatonin in oxidative neurotoxicity | Q41643085 | ||
| In vitro and in vivo protective effects of melatonin against glutamate oxidative stress and neurotoxicity | Q41643090 | ||
| Neuroprotective action of the pineal hormone melatonin against excitotoxicity. Receptor abuse-dependent antagonism (RADA). | Q41643096 | ||
| Free radical generation during brief period of cerebral ischemia may trigger delayed neuronal death | Q43469510 | ||
| Nimodipine does not improve neurologic outcome after 14 minutes of cardiac arrest in cats | Q46942674 | ||
| LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia | Q48095150 | ||
| Effects of an A1 adenosine receptor agonist on the neurochemical, behavioral and histological consequences of ischemia | Q48141530 | ||
| Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia | Q48212116 | ||
| The antioxidant LY231617 reduces global ischemic neuronal injury in rats | Q48290608 | ||
| Identity of the dorsal hippocampal region most vulnerable to cerebral ischemia | Q48332436 | ||
| alpha-Phenyl-tert-butyl-nitrone (PBN) attenuates hydroxyl radical production during ischemia-reperfusion injury of rat brain: an EPR study | Q48377200 | ||
| Neuroprotective efficacy and mechanisms of novel pyrrolopyrimidine lipid peroxidation inhibitors in the gerbil forebrain ischemia model | Q48468054 | ||
| Neuroprotective effects of pterin-6-aldehyde in gerbil global brain ischemia: comparison with those of alpha-phenyl-N-tert-butyl nitrone | Q48508437 | ||
| Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons | Q48510029 | ||
| Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia | Q48682171 | ||
| Melatonin administration protects CA1 hippocampal neurons after transient forebrain ischemia in rats | Q48708580 | ||
| The neurologic effects of thiopental therapy following experimental cardiac arrest in cats | Q48915809 | ||
| Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. | Q48955152 | ||
| Pattern of neuronal vulnerability in the cat hippocampus after one hour of global cerebral ischemia | Q49160723 | ||
| Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo | Q60585583 | ||
| P433 | issue | 3 | |
| P921 | main subject | melatonin | Q180912 |
| cerebral infarction | Q1209150 | ||
| P304 | page(s) | 186-192 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Archives of Medical Research | Q15751494 |
| P1476 | title | Neuroprotective effect of melatonin on brain damage induced by acute global cerebral ischemia in cats | |
| P478 | volume | 32 |
| Q46742291 | Chronic and acute melatonin effects in gerbil global forebrain ischemia: long-term neural and behavioral outcome |
| Q43980513 | Enhanced protection by melatonin and meloxicam combination in a middle cerebral artery occlusion model of acute ischemic stroke in rat. |
| Q28388335 | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases |
| Q48280385 | Long-term morphological and functional evaluation of the neuroprotective effects of post-ischemic treatment with melatonin in rats. |
| Q33839140 | Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans |
| Q37172713 | Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury |
| Q26999039 | Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia |
| Q35992930 | Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke |
| Q33757816 | The antiapoptotic activity of melatonin in neurodegenerative diseases |
| Q34831410 | The hippocampus and cognitive impairments |
| Q35076749 | The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion |
| Q30490890 | Time-of-day determines neuronal damage and mortality after cardiac arrest |
| Q36021253 | When melatonin gets on your nerves: its beneficial actions in experimental models of stroke |
Search more.